文献速递慢性肾脏病肾血管病与高血压

心血管-肾脏-代谢综合征:新风险预测方程

Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations.
PubMed 文献 · Kidney Int Rep · 2024-06-06

美国心脏协会工作组将心血管疾病、慢性肾脏病和代谢综合征整合为心血管-肾脏-代谢(CKM)综合征,提出5期分期共识,并开发了纳入eGFR和白蛋白尿的PREVENT风险预测方程,尽管存在局限,仍是心血管风险预测的重要进展。

要点

  • CKM综合征整合代谢危险因素、CKD与心血管系统的多向关系。
  • CKM共识定义5个分期,并开发PREVENT风险预测方程。
  • PREVENT方程在传统心血管代谢因素外纳入eGFR和白蛋白尿。

核心结论

  • 将心血管、肾脏和代谢疾病整合为CKM综合征并开发PREVENT方程是心血管风险预测的重要进步。

研究设计与样本

  • 美国心脏协会成立由心脏科、内分泌科和肾内科专家组成的工作组,采用共识方法定义CKM综合征并开发风险预测方程。

主要发现

  • 工作组提出CKM综合征术语,反映代谢危险因素、CKD和心血管系统之间的多向关系。
  • 工作组采用共识方法定义了CKM的5个分期。
  • 工作组随后开发了PREVENT方程,在传统心血管和代谢因素外纳入eGFR和白蛋白尿作为变量。

关键数值与推荐

  • CKM综合征定义为包含代谢危险因素、CKD和心血管系统多向关系的单一实体。
  • CKM共识定义包含5个分期。
  • PREVENT方程纳入eGFR和白蛋白尿以及传统心血管和代谢因素。

临床怎么用

  • 临床应应用PREVENT方程进行心血管风险预测,以促进CKM综合征的早期和更适当治疗与预防。

局限性

  • PREVENT方程存在若干局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Associations of chronic kidney disease (CKD) with metabolic syndrome and cardiovascular disease (CVD) have long been recognized. Until recently, such associations were mainly limited to interrelationships between either heart and kidney, heart and metabolic syndrome, or metabolic syndrome and kidney. It is the merit of the American Heart Association (AHA) to have set up a work group of cardiologists, endocrinologists, and nephrologists for the purpose of combining all 3 disorders in a single entity, as an appreciation of their pathophysiological interrelatedness. To this end, they proposed the term cardiovascular-kidney-metabolic (CKM) syndrome, which reflects multidirectional relationships among metabolic risk factors, CKD, and the cardiovascular system. Following a consensus approach in defining CKM with 5 stages, the work group subsequently developed new risk prediction equations, named predicting risk of CVD events (PREVENT) equations, which included estimated glomerular filtration rate (eGFR) and albuminuria as variables in addition to traditional cardiovascular and metabolic factors. Despite several limitations, this development is a major step forward in cardiovascular risk prediction. Its clinical application should translate into earlier, more appropriate treatment and prevention of CKM syndrome.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Massy ZA, Drueke TB. Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations. Kidney Int Rep. 2024. PMID: 39291205. doi:10.1016/j.ekir.2024.05.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。